Page last updated: 2024-09-03

vadimezan and okadaic acid

vadimezan has been researched along with okadaic acid in 1 studies

Compound Research Comparison

Studies
(vadimezan)
Trials
(vadimezan)
Recent Studies (post-2010)
(vadimezan)
Studies
(okadaic acid)
Trials
(okadaic acid)
Recent Studies (post-2010) (okadaic acid)
272161013,8652658

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baguley, BC; Ching, LM; Philpott, M1

Other Studies

1 other study(ies) available for vadimezan and okadaic acid

ArticleYear
The antitumour agent 5,6-dimethylxanthenone-4-acetic acid acts in vitro on human mononuclear cells as a co-stimulator with other inducers of tumour necrosis factor.
    European journal of cancer (Oxford, England : 1990), 2001, Volume: 37, Issue:15

    Topics: Antineoplastic Agents; Cell Culture Techniques; Cytokines; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Humans; Leukocytes, Mononuclear; Lipopolysaccharide Receptors; Lipopolysaccharides; NF-kappa B; Okadaic Acid; Salicylic Acid; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha; Xanthenes; Xanthones

2001